Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$3.12 +0.17 (+5.94%)
As of: Aug 21, 2026 · 1:31 PM EDT

Scinai Immunotherapeutics (SCNI) Non-Current Debt (2018 - 2026)

Scinai Immunotherapeutics (SCNI) posted Non-Current Debt of $287000.0 for Q1 2026, down 2.38% sequentially from $294000.0 in Q4 2025.

Scinai Immunotherapeutics (SCNI) Non-Current Debt (2018 - 2026) Analysis & Trends

Scinai Immunotherapeutics has reported Non-Current Debt for 9 years, with the latest figure at $287000.0 in Q1 2026.

  • Quarterly Non-Current Debt changed N/A year-over-year to $287000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $287000.0 (changed N/A YoY) and the FY2025 annual result came in at $294000.0, up 13.08% from the prior year.
  • Non-Current Debt eased to $287000.0 in Q1 2026 per SCNI's latest filing, from $294000.0 in the prior quarter.
  • Over five years, Non-Current Debt peaked at $23.3 million in Q2 2023 and troughed at $260000.0 in Q4 2024.
  • A 5-year average of $13.0 million and a median of $18.6 million in 2023 frame the typical range for Non-Current Debt.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Debt slumped 99.98% in 2022, then jumped 56.92% in 2023.
  • Over 5 years, Non-Current Debt stood at $20.1 million in 2022, then declined by 3.56% to $19.4 million in 2023, then plunged by 98.66% to $260000.0 in 2024, then grew by 13.08% to $294000.0 in 2025, then declined by 2.38% to $287000.0 in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $287000.0, $294000.0, and $293000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Vertex Pharmaceuticals 139.35 Bn 131.50 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.12 Bn 78.12 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn -
4 Moderna 58.98 Bn 53.84 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 42.08 Bn 36.99 Bn 1.53 Bn 882.16 Mn
6 Alnylam Pharmaceuticals 31.61 Bn 28.30 Bn 992.69 Mn -
7 BioNTech SE 27.98 Bn 9.59 Bn 668.28 Mn 360.97 Mn
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.30 Bn 26.47 Bn - 8.96 Bn
10 Scinai Immunotherapeutics 11.81 Mn -3.10 Bn -1.12 Mn 287,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 287,000.00
Dec 31, 2025 294,000.00
Jun 30, 2025 293,000.00
Dec 31, 2024 260,000.00
Sep 30, 2024 280,000.00
Jun 30, 2024 19.82 Mn
Mar 31, 2024 19.51 Mn
Dec 31, 2023 19.37 Mn
Sep 30, 2023 18.60 Mn
Jun 30, 2023 23.29 Mn
Mar 31, 2023 21.85 Mn
Dec 31, 2022 20.08 Mn
Sep 30, 2022 15.63 Mn
Jun 30, 2022 14.84 Mn
Mar 31, 2022 20.52 Mn
Dec 31, 2021 27.16 Mn
Sep 30, 2021 19.97 Mn
Jun 30, 2021 64.25 Bn
Mar 31, 2021 62.35 Bn
Dec 31, 2020 60.42 Bn